MedTrace Logo

Red Blood Cell Precursor Formulation to Determine Increased Production

NCT01701531 · Status: WITHDRAWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL

Last updated 2016-05-05

No results posted yet for this study

Summary

The objective of this study is to measure the change in hemoglobin levels after the administration of an amino acid based, RBC precursor formulation.

Conditions

Interventions

DRUG

RBCPF

Sponsors & Collaborators

  • Targeted Medical Pharma

    lead INDUSTRY

Principal Investigators

  • Lawrence May, MD · Lawrence May MD, Inc

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01701531 on ClinicalTrials.gov